ASHLEIGH KINON: Open Payments
NPI 1780141069 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 50 payments from 17 companies in 2025. Trend: 2023 $1,557 · 2024 $1,607 · 2025 $1,056
Food & beverage: $886Education: $170
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $250 |
| GENZYME CORPORATION | 10 | $145 |
| ABBVIE INC. | 5 | $92 |
| Galderma Laboratories, L.P. | 4 | $78 |
| UCB, Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $65 |
| Janssen Biotech, Inc. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Incyte Corporation | 2 | $47 |
| Amgen Inc. | 2 | $43 |
Products named: DUPIXENT, ILUMYA, SKYRIZI, Bimzelx, TALTZ, NEMLUVIO, TREMFYA, OPZELURA.
Industry payments across SC — which companies pay providers there.
